Skip to content

Clinical trials

Observational Cardiomyopathy, Hypertrophic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Phase: Observational Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20132
20141
20151
20171
20193
20212
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Wayne State University2
Brigham and Women's Hospital1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Montreal Heart Institute1
Tenaya Therapeutics1
University of Alberta1
University of British Columbia1
University of Virginia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic13
Cardiomyopathy, Dilated4
Cardiomyopathies2
Cardiomyopathy, Restrictive2
Death, Sudden, Cardiac2
Long QT Syndrome2
Aortic Valve Insufficiency1
Aortic Valve Stenosis1
Arrhythmogenic Right Ventricular Dysplasia1
Cardiomyopathy, Hypertrophic, Familial1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.